Daniel Swinson
Leeds Teaching Hospitals NHS Trust(GB)St James's University Hospital(GB)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment, Colorectal Cancer Treatments and Studies, Nanoplatforms for cancer theranostics
Most-Cited Works
- → Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial(2013)601 cited
- → First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials(2017)383 cited
- → Tumour necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables(2002)184 cited
- → Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer(2021)183 cited
- → Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways.(2004)152 cited
- → Tumor Necrosis Correlates With Angiogenesis and Is a Predictor of Poor Prognosis in Malignant Mesothelioma *